Literature DB >> 19494255

Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone.

Yuying You1, Hong Zhao, Yue Wang, Robert H Carter.   

Abstract

Marginal zone (MZ) B cells are absent in CD19(-/-) mice. Possible causes include an intrinsic defect in B cells and/or a secondary defect in the extrinsic MZ microenvironment as a result of changes in B cell differentiation in mice lacking CD19. Cells in the MZ also include MZ macrophages (MZM) and MZ dendritic cells (DC). Although CD19 is only expressed on B cells, SIGN-R1(+) MZM are absent and CD11c(+) MZ DC distribution is abnormal in CD19(-/-) mice. Adoptively transferred B cells from normal mice are able to reconstitute MZ B cells in CD19(-/-) mice. In contrast, CD19(-/-) B cells could not enter the MZ of the normal mice. Furthermore, MZM distribution and MZ DC distribution are restored following MZ B cell reconstitution in CD19(-/-) mice. Thus, MZ B cells are required for MZM differentiation and MZ DC localization, but the deficiency of MZ B cells in CD19(-/-) mice is caused by a defect of intrinsic B cell signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494255      PMCID: PMC2747094          DOI: 10.4049/jimmunol.0804295

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.

Authors:  F Martin; J F Kearney
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  The physiologic role of CD19 cytoplasmic tyrosines.

Authors:  Yue Wang; Stephen R Brooks; Xiaoli Li; Amy N Anzelon; Robert C Rickert; Robert H Carter
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

4.  Integrin-mediated long-term B cell retention in the splenic marginal zone.

Authors:  Theresa T Lu; Jason G Cyster
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

5.  Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

Authors:  Kalaya Attanavanich; John F Kearney
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 6.  Cells in the marginal zone of the spleen.

Authors:  G Kraal
Journal:  Int Rev Cytol       Date:  1992

7.  The recirculating B cell pool contains two functionally distinct, long-lived, posttransitional, follicular B cell populations.

Authors:  Annaiah Cariappa; Cristian Boboila; Stewart T Moran; Haoyuan Liu; Hai Ning Shi; Shiv Pillai
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

8.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Authors:  Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

9.  B cells are crucial for both development and maintenance of the splenic marginal zone.

Authors:  Martijn A Nolte; Ramon Arens; Manfred Kraus; Marinus H J van Oers; Georg Kraal; René A W van Lier; Reina E Mebius
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

10.  Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone.

Authors:  Mikael C I Karlsson; Rodolphe Guinamard; Silvia Bolland; Marko Sankala; Ralph M Steinman; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  19 in total

Review 1.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

2.  mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Authors:  Naresh Kumar Meena; Shakti Prasad Pattanayak; Yael Ben-Nun; Sandrine Benhamron; Saran Kumar; Emmanuelle Merquiol; Nadine Hövelmeyer; Galia Blum; Boaz Tirosh
Journal:  Immunology       Date:  2018-09-16       Impact factor: 7.397

3.  Macrophage heterogeneity in lymphoid tissues.

Authors:  Joke M M den Haan; Luisa Martinez-Pomares
Journal:  Semin Immunopathol       Date:  2013-04-12       Impact factor: 9.623

4.  Foxo1 regulates marginal zone B-cell development.

Authors:  Jing Chen; Jose J Limon; Caroline Blanc; Stanford L Peng; David A Fruman
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

5.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

Review 6.  Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.

Authors:  Tracy L McGaha; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

7.  Marginal zone B cells regulate antigen capture by marginal zone macrophages.

Authors:  Yuying You; Riley C Myers; Larry Freeberg; Jeremy Foote; John F Kearney; Louis B Justement; Robert H Carter
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 8.  The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.

Authors:  FuNien Tsai; Harris Perlman; Carla M Cuda
Journal:  Clin Immunol       Date:  2016-10-22       Impact factor: 3.969

9.  B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.

Authors:  Burles A Johnson; David J Kahler; Babak Baban; Phillip R Chandler; Baolin Kang; Michiko Shimoda; Pandelakis A Koni; Jeanene Pihkala; Bojan Vilagos; Meinrad Busslinger; David H Munn; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

10.  Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.

Authors:  Marta Cuenca; Xavier Romero; Jordi Sintes; Cox Terhorst; Pablo Engel
Journal:  J Immunol       Date:  2015-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.